- Home
- Therapeutic Areas
- Basic Research
- Cardiovascular Disease Models
- Animal Models of Cardiovascular Diseases
- Custom Animal Model Development
- Custom Animal Models of Atherosclerosis
- Custom Animal Models of Hypertension
- Custom Animal Models of Thrombosis
- Custom Animal Models of Cardiac Ischemia-Reperfusion
- Custom Animal Models of Arrhythmia
- Custom Animal Models of Heart Failure
- Custom Animal Models of Heart Valve Disease
- Custom Animal Models of Hypertrophic Cardiomyopathy
- Custom Animal Models of Cardiovascular Infection
- Transgenic Animal Models of Cardiovascular Diseases
- Custom Animal Model Development
- Cardiac Organoids
- Modeling Cardiovascular Diseases with Cardiomyocytes
- Animal Models of Cardiovascular Diseases
- Biomarker Assay Services
- Biospecimen Collection and Analysis Services
- Research Tools
- Cardiovascular Disease Models
- Discovery & Development
- Cardiovascular Drug Discovery
- Drug Discovery by Modality
- Drug Discovery by Target
- Drug Target Identification & Validation
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
- HMG-CoA Reductase
- P2Y12 Receptor
- Thrombin
- Voltage-Dependent Ca2+ Channels (VDCCs)
- Beta-Adrenoceptor
- Angiotensin Converting Enzyme (ACE)
- Angiotensin II Receptor
- Natriuretic Peptide Receptor (NPR)
- ApoA-I
- PDE3
- Preclinical Research
- Diagnostic Development
- R&D for Cardiovascular Implants
- Cardiovascular Drug Discovery
- Platforms
- Virtual Booth
- Company
